BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, Burgos CB, Sempere J. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases 2019; 7(14): 1732-1752 [PMID: 31417920 DOI: 10.12998/wjcc.v7.i14.1732]
URL: https://www.wjgnet.com/1007-9327/full/v7/i14/1732.htm
Number Citing Articles
1
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune TechniquesModern Medical Laboratory Journal 2020; 3(2): 100 doi: 10.30699/mmlj17.3.1.100
2
Dina Ioffe, Pooja Phull, Efrat Dotan. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based ReviewCancer Management and Research 2021; : 8085 doi: 10.2147/CMAR.S276104
3
Cosmas Rinaldi Adithya Lesmana, Baiq Kirana D. Mandasari. Immunosuppression2020;  doi: 10.5772/intechopen.94754
4
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, Sebastiao N. Martins-Filho, Quan Li, Melania Pintilie, Jessica Weiss, Vibha Raghavan, Michael Cabanero, Robert E. Denroche, Julie M. Wilson, Cristiane Metran-Nascente, Ayelet Borgida, Shawn Hutchinson, Anna Dodd, Michael Begora, Dianne Chadwick, Stefano Serra, Jennifer J. Knox, Steven Gallinger, David W. Hedley, Lakshmi Muthuswamy, Ming-Sound Tsao. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancersScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90049-1
5
Gülşah BAYRAM ILIKAN, İ̇lkay AKMANGİT. Percutaneous Transhepatic Cholangiography, Percutaneous Biliary Drainage and Metallic Endoprotesis Applications in Malign Biliary ObstructionsJournal of Contemporary Medicine 2020; 11(1): 97 doi: 10.16899/jcm.764141
6
Jieling Zheng, Shaobo Yao. [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging 2020; 47(9): 2078 doi: 10.1007/s00259-020-04847-2
7
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J Borad, Ghassan K Abou-Alfa, Ping Jiang, Christine F Lihou, Huiling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangementsFuture Oncology 2020; 16(30): 2385 doi: 10.2217/fon-2020-0429
8
Josep Darbà, Alicia Marsà. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)Expert Review of Pharmacoeconomics & Outcomes Research 2021; 21(3): 425 doi: 10.1080/14737167.2021.1842201